[Preliminary clinical experiences and problems of long-term therapy of diabetes mellitus using 2nd generation sulfonylurea derivatives (glibenclamide)].
D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000378:metabolism; D004351:Drug Resistance; D005905:Glyburide / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007328:Insulin / Q000378:metabolism; D008134:Long-Term Care; D008875:Middle Aged; D013453:Sulfonylurea Compounds / Q000627:therapeutic use
D007328:Insulin; D013453:Sulfonylurea Compounds; D005905:Glyburide
Erste klinische Erfahrungen und Probleme einer Langzeittherapei des Diabetes mellitus mit Sulfonylharnstoffderivaten der 2. Generation (Glibenklamid.